These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 3915549

  • 1. [Beta-pancreatic function in subjects with thalassemia. A 4-year follow-up].
    Zanini R, Briante G, Cantone P, Sticca M, Grasso U.
    Pediatr Med Chir; 1985; 7(5):749-53. PubMed ID: 3915549
    [Abstract] [Full Text] [Related]

  • 2. Increased risk of diabetes mellitus in beta- thalassemia major due to iron overload.
    Zuppinger K, Molinari B, Hirt A, Imbach P, Gugler E, Tönz O, Zurbrügg RP.
    Helv Paediatr Acta; 1979; 34(3):197-207. PubMed ID: 500381
    [Abstract] [Full Text] [Related]

  • 3. [Chelating therapy in beta-thalassemia].
    Musumeci S, Romeo MA, Di Gregorio F, Schiliró G, Russo G.
    Pediatr Med Chir; 1982; 4(1-2):55-9. PubMed ID: 7111040
    [Abstract] [Full Text] [Related]

  • 4. Quality of life in transfusion-dependent thalassaemia patients on desferrioxamine treatment.
    Dahlui M, Hishamshah MI, Rahman AJ, Aljunid SM.
    Singapore Med J; 2009 Aug; 50(8):794-9. PubMed ID: 19710979
    [Abstract] [Full Text] [Related]

  • 5. Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion.
    Merkel PA, Simonson DC, Amiel SA, Plewe G, Sherwin RS, Pearson HA, Tamborlane WV.
    N Engl J Med; 1988 Mar 31; 318(13):809-14. PubMed ID: 3281000
    [Abstract] [Full Text] [Related]

  • 6. Insulin resistance and beta cell function in chronically transfused patients of thalassemia major.
    Suvarna J, Ingle H, Deshmukh CT.
    Indian Pediatr; 2006 May 31; 43(5):393-400. PubMed ID: 16735760
    [Abstract] [Full Text] [Related]

  • 7. [Continuous subcutaneous deferoxamine infusions in thalassemia major. Improvement in glucose tolerance].
    Krüger N, Stubbe P, Tillmann W, Schröter W.
    Dtsch Med Wochenschr; 1986 May 02; 111(18):698-701. PubMed ID: 3486106
    [Abstract] [Full Text] [Related]

  • 8. Long-term intravenous deferoxamine treatment for noncompliant transfusion-dependent beta-thalassemia patients.
    Tamary H, Goshen J, Carmi D, Yaniv I, Kaplinsky C, Cohen IJ, Zaizov R.
    Isr J Med Sci; 1994 Aug 02; 30(8):658-64. PubMed ID: 8045754
    [Abstract] [Full Text] [Related]

  • 9. Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.
    Giardina PJ, Grady RW.
    Semin Hematol; 1995 Oct 02; 32(4):304-12. PubMed ID: 8560288
    [Abstract] [Full Text] [Related]

  • 10. Study of A- and B-cell function in beta-thalassemia major.
    Maioli M, Pacifico A, Frulio T, Longinotti M.
    Acta Diabetol Lat; 1983 Oct 02; 20(2):143-52. PubMed ID: 6349202
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Linear growth in homozygous beta-thalassemia and beta-thalassemia/hemoglobin E patients under different treatment regimens.
    Viprakasit V, Tanphaichitr VS, Mahasandana C, Assteerawatt A, Suwantol L, Veerakul G, Kankirawatana S, Pung-Amritt P, Suvatte V.
    J Med Assoc Thai; 2001 Jul 02; 84(7):929-41. PubMed ID: 11759973
    [Abstract] [Full Text] [Related]

  • 13. Glucose tolerance and beta-cell secretion in patients with thalassaemia major.
    Mangiagli A, Italia S, Campisi S.
    J Pediatr Endocrinol Metab; 1998 Jul 02; 11 Suppl 3():985-6. PubMed ID: 10091179
    [No Abstract] [Full Text] [Related]

  • 14. [Evaluation of the efficacy of chelation therapy with deferoxamine in patients with thalassemia major].
    Rodríguez Galindo C, Ortega Aramburu JJ, Alonso JL, Albisu M, Casaldáliga J, Díaz de Heredia C, Olivé T, Bastida P.
    Med Clin (Barc); 1994 May 21; 102(19):721-4. PubMed ID: 8041200
    [Abstract] [Full Text] [Related]

  • 15. Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
    Gaziev J, Sodani P, Polchi P, Andreani M, Lucarelli G.
    Ann N Y Acad Sci; 2005 May 21; 1054():196-205. PubMed ID: 16339666
    [Abstract] [Full Text] [Related]

  • 16. Zinc deficiency aggravates abnormal glucose metabolism in thalassemia major patients.
    Dehshal MH, Hooghooghi AH, Kebryaeezadeh A, Kheirabadi M, Kazemi S, Nasseh A, Shariftabrizi A, Pasalar P.
    Med Sci Monit; 2007 May 21; 13(5):CR235-9. PubMed ID: 17476196
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. High transfusion in children with beta-thalassemia/Hb E: clinical and laboratory assessment of 18 cases.
    Torcharus K, Withayathawornwong W, Sriphaisal T, Krutvacho T, Arnutti P, Suwanasophorn C.
    Southeast Asian J Trop Med Public Health; 1993 May 21; 24 Suppl 1():96-9. PubMed ID: 7886617
    [Abstract] [Full Text] [Related]

  • 19. Pancreatic sonography in thalassemia major.
    Erttmann R, Hausdorf G, Landbeck G.
    Klin Padiatr; 1983 Mar 21; 195(2):97-9. PubMed ID: 6855148
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.